Ozempic 1 MG/dose (4 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F13MH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,698
Award facts
- Contract value 100% obligated
- $19,698.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) 3 mL vials, a diabetes management medication. This firm fixed-price delivery order carries a ceiling value of $19,698.05 and is scheduled for completion by January 6, 2026. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal vendor for military and veteran healthcare systems. The company's comprehensive federal contract portfolio with DLA encompasses a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. This delivery order for Ozempic exemplifies AmerisourceBergen's role in supporting the Defense Health Agency and other federal healthcare systems through flexible contracting mechanisms designed to ensure consistent pharmaceutical supply chain support for military personnel and beneficiaries.
Quick answers
Who was awarded contract SPE2DR26F13MH?
SPE2DR26F13MH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26F13MH worth?
The government has obligated $19,698 on SPE2DR26F13MH.
Is contract SPE2DR26F13MH an order under another contract?
Yes. SPE2DR26F13MH is a delivery order under SPE2DR25D1110, an indefinite delivery contract.
Was contract SPE2DR26F13MH competed?
The extent of competition for SPE2DR26F13MH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award